03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Sue Fletcher: no photograph is held, so the academic plate is shown instead.
Academic
Sue Fletcher
Emeritus Professor, AO, RNA therapeutics pioneer, Murdoch University
1
Nov 2026to date
1
press citation on 1 topic since 10 Nov 2026 · last quoted 10 Nov 2026
02 Quoted on · 1 of 29 topics
Sue Fletcher: key facts
- Kind of voice
- Academic
- Role
- Emeritus Professor, AO, RNA therapeutics pioneer, Murdoch University
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 10 Nov 2026
04 The signal · where Sue Fletcher sits on rare diseases
Ranked 49= of 100 voices quoted in the press on rare diseases, level with 51 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 49=Jonathan GlassAcademicMD, director of the Emory ALS Center and co-principal investigator of the study1
- 49=Kiki SyradAcademicDirector of Research and Innovation at Great Ormond Street Hospital1
- 49=Sue FletcherAcademicEmeritus Professor, AO, RNA therapeutics pioneer, Murdoch University1
- 49=Anastasia ZekeridouAcademicNeurologist and researcher at Mayo Clinic, Rochester1
- 49=Sean PittockAcademicChair of the department of neurology at Mayo Clinic1
Showing the leaders and the ranks around 49=, of 100 voices · See every voice on the topic →
05 On the record · press
What Sue Fletcher has said
By outlet · linked articles
- technologynetworks.com1
Where Sue Fletcher has been quoted
- 01Patient-Derived Neuron Models Support Development of MND Therapytechnologynetworks.com · 10 Nov 2026
Verbatim
“A drug that works in cells in a dish in the lab must be able to travel through the body and reach the target cells in the nervous system in sufficient amounts to be effective”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.